About Us

About PharmaCircle

Since 2003, PharmaCircle has been providing clients with the integrated data, powerful analysis tools and industry knowledge needed to solve complex, real world challenges in pharmaceutical development and innovation.

PharmaCircle serves commercial and emerging stage life sciences companies and suppliers from around the world, including pharmaceutical, biologics/vaccine, generics, OTC, drug/device delivery, medical device/diagnostics, veterinary, CDMO, packaging, and specialty chemical companies. Most of the top 50 pharmaceutical and biologics companies are longstanding clients. PharmaCircle provides three subscription service solutions: Professional, Elite and Premium.


PharmaCircle Professional delivers a comprehensive view into drug, biologics and combination product development and innovation worldwide, and a complete perspective of the competitive market landscape.

Learn More


PharmaCircle Elite builds upon and expands the core content and capabilities of PharmaCircle Professional, adding powerful apps and research tools.

Learn More


PharmaCircle Premium delivers seamless integration of development, clinical, safety, regulatory, manufacturing and commercial content into one online source.

Learn More

PharmaCircle’s Enterprise Solution

PharmaCircle’s Premium Subscription Service connects pipeline and product information for drugs, biologics and combination products with formulation and component details, and provides detailed analysis on more than 7,000 drug delivery technologies and devices.

Powered by PharmaCircle’s TURBOARD business intelligence analytics software, multi-parameter searches and analysis can be performed across hundreds of variables. Development summaries, full-text regulatory document search capabilities, patent exclusivity tracking, deals and funding transactions analysis, supply chain data, and company profiles help to further streamline research and identify new opportunities.

PharmaCircle’s Premium Subscription Service includes concierge-level support and expert insight.